Pulmonx Corp (NASDAQ: LUNG) on Friday, soared 10.46% from the previous trading day, before settling in for the closing price of $1.53. Within the past 52 weeks, LUNG’s price has moved between $1.47 and $9.37.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -19.80% annually for the last half of the decade. The company achieved an average annual earnings per share of -7.43%. With a float of $35.94 million, this company’s outstanding shares have now reached $40.74 million.
Pulmonx Corp (LUNG) Insider Updates
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Pulmonx Corp is 11.80%, while institutional ownership is 84.55%. The most recent insider transaction that took place on Jun 12 ’25, was worth 25,280. In this transaction Director of this company sold 8,000 shares at a rate of $3.16, taking the stock ownership to the 87,024 shares. Before that another transaction happened on Jun 13 ’25, when Company’s Director proposed sale 5,438 for $3.01, making the entire transaction worth $16,368.
Pulmonx Corp (LUNG) Performance Highlights and Predictions
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.36 earnings per share (EPS) for the period topping the consensus outlook (set at -0.44) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -7.43% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.98% during the next five years compared to -19.80% drop over the previous five years of trading.
Pulmonx Corp (NASDAQ: LUNG) Trading Performance Indicators
Pulmonx Corp (LUNG) is currently performing well based on its current performance indicators. A quick ratio of 4.62 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.76.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.43, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.33 in one year’s time.
Technical Analysis of Pulmonx Corp (LUNG)
Let’s dig in a bit further. During the last 5-days, its volume was 0.75 million. That was better than the volume of 0.45 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 45.15%.
During the past 100 days, Pulmonx Corp’s (LUNG) raw stochastic average was set at 3.94%, which indicates a significant decrease from 83.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1046 in the past 14 days, which was lower than the 0.3009 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.4518, while its 200-day Moving Average is $5.1048. However, in the short run, Pulmonx Corp’s stock first resistance to watch stands at $1.7733. Second resistance stands at $1.8567. The third major resistance level sits at $1.9783. If the price goes on to break the first support level at $1.5683, it is likely to go to the next support level at $1.4467. Assuming the price breaks the second support level, the third support level stands at $1.3633.
Pulmonx Corp (NASDAQ: LUNG) Key Stats
Market capitalization of the company is 68.87 million based on 40,747K outstanding shares. Right now, sales total 83,790 K and income totals -56,390 K. The company made 23,860 K in profit during its latest quarter, and -15,170 K in sales during its previous quarter.
